# Silence Therapeutics (SLN) — Analyst Forecast

SLN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sln/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 6 | 0 | 1 | 7 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 11, 2026 | Morgan Stanley | Maintained | Overweight | $32.00 |
| Jun 24, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| Jun 17, 2026 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| Mar 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| Sep 16, 2025 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| Aug 8, 2025 | Chardan Capital | Maintained | Buy | $35.00 |
| Jun 13, 2025 | Chardan Capital | Maintained | Buy | $35.00 |
| Jun 13, 2025 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| May 9, 2025 | Chardan Capital | Maintained | Buy | $35.00 |
| May 9, 2025 | Morgan Stanley | Maintained | Overweight | $25.00 |
| May 9, 2025 | Goldman Sachs | Maintained | Sell | $3.00 |
| Mar 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| Mar 5, 2025 | Morgan Stanley | Maintained | Overweight | $45.00 |
| Mar 4, 2025 | Goldman Sachs | Maintained | Sell | $4.00 |
| Mar 4, 2025 | BMO Capital | Maintained | Outperform | $25.00 |
| Feb 11, 2025 | Goldman Sachs | Initiated Coverage | Sell | $6.00 |
| Feb 3, 2025 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| Jan 29, 2025 | HC Wainwright & Co. | Maintained | Buy | $75.00 |
| Dec 10, 2024 | Chardan Capital | Maintained | Buy | $55.00 |
| Dec 9, 2024 | HC Wainwright & Co. | Maintained | Buy | $75.00 |

## Frequently Asked Questions

### Is SLN a buy, sell, or hold?

Analysts covering Silence Therapeutics currently average a Buy rating: 6 buy, 0 hold and 1 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on SLN?

On Aug 11, 2026, Morgan Stanley maintained Silence Therapeutics at Overweight with a price target of $32.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).